1AI 0.00% 0.9¢ algorae pharmaceuticals limited

AGM, page-183

  1. 16,703 Posts.
    lightbulb Created with Sketch. 2382
    Barry Snow described the results of the study as a "Rubiks Cube" where understanding how the results came about is a puzzle. That is what they are trying to do now, looking at all the characteristics of the individual patients and seeing if it has any relationship to the responses at a given dose. The longer the study time, the more data points they have, the better the chances they have of getting some insight.

    Personally I don't believe they will pursue the PD use of NTcell if they cannot find some reasonable good scioentific evidence of efficacy in the data from the trial over 18-24 months. They would need to see a consistent trend which leads to statistical significance to seek and allocate more funds.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $2.066K 207.1K

Buyers (Bids)

No. Vol. Price($)
3 523973 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 713611 2
View Market Depth
Last trade - 15.47pm 29/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.